Bausch Health Co. Inc. (BHC) Posts Q4 Adjusted EBITDA of $898 Million, Revs Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
Cowen Defends Bausch Health Companies (BHC); 'Add Here'
February 19, 2020 11:37 AM ESTCowen analyst Ken Cacciatore reiterated an Outperform rating and $40.00 price target on Bausch Health Companies (NYSE: BHC), saying there is no change to the thesis and investors should add here.
The analyst commented, "Q4 revs were slightly above the Street, while earnings... More
Guggenheim Says Bausch Health Companies (BHC) Sell-Off 'Overdone'
February 19, 2020 11:17 AM ESTGuggenheim analyst Dana Flanders came out to defend Bausch Health Companies (NYSE: BHC), saying the sell-off is overdone.
incremental updates unlikely to inspire near-term confidence, but sell-off overdone.The analyst reiterated a Buy rating and $36.00 price target on... More
